Skip to main content

Advertisement

Table 1 Baseline characteristics of demographic, clinical and laboratory data

From: Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study

variables  
Age in years, mean ± SD 31.7 ± 6.6
Male, % 85.1%
HBV genotype C, % 100%
Baseline ALT, IU/L 216.3 ± 169.7
Baseline HBV DNA(log10copies/ml) 8.5 ± 0.8
Baseline HBeAg(log10) 2.8 ± 0.4
BaselineHBsAg(log10) 3.7 ± 0.5